| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| STING agonist-12 |
STING AGONIST-12 |
2259624-71-8 |
詳細(xì)
|
| JQAD1 |
化合物JQAD1 |
2417097-18-6 |
詳細(xì)
|
| Matairesinoside |
羅漢松脂苷 |
23202-85-9 |
詳細(xì)
|
| 2-MPPA |
2-(3-sulfanylpropyl)pentanedioic acid |
254737-29-6 |
詳細(xì)
|
| MARK4 inhibitor 1 |
MARK4 inhibitor 1 |
2271081-58-2 |
詳細(xì)
|
| M2N12 |
M2N12 |
2376577-06-7 |
詳細(xì)
|
| G140 |
化合物G140 |
2369751-07-3 |
詳細(xì)
|
| E64FC26 |
E64FC26 |
2285446-62-8 |
詳細(xì)
|
| HWL-088 |
HWL-088 |
2378617-96-8 |
詳細(xì)
|
| IHMT-PI3Kδ-372 |
化合物IHMT-PI3KΔ-372 |
2429889-62-1 |
詳細(xì)
|
| IL-17 modulator 4 |
IL-17調(diào)節(jié)劑4 |
2446803-65-0 |
詳細(xì)
|
| NF-κΒ activator 1 |
化合物NF-ΚΒ ACTIVATOR 1 |
2387524-59-4 |
詳細(xì)
|
| BSJ-4-116 |
化合物BSJ-4-116 |
2519823-34-6 |
詳細(xì)
|
| DHODH-IN-16 |
化合物DHODH-IN-16 |
2511248-11-4 |
詳細(xì)
|
| KB-0742 dihydrochloride |
KB-0742 dihydrochloride |
2416874-75-2 |
詳細(xì)
|
| Evifacotrep |
依法曲普 |
2413739-88-3 |
詳細(xì)
|
| EZM0414 |
EZM0414 |
2411748-50-8 |
詳細(xì)
|
| ACSS2-IN-2 |
化合物ACSS2-IN-2 |
2332820-04-7 |
詳細(xì)
|
| DDO-7263 |
化合物DDO-7263 |
2254004-96-9 |
詳細(xì)
|
| Phenazine-1-carboxylic acid |
申嗪霉素 |
2538-68-3 |
詳細(xì)
|
| SM-360320 |
6-氨基-7,9-二氫-2-(2-甲氧基乙氧基)-9-(苯甲基)-8H-嘌呤-8-酮 |
226907-52-4 |
詳細(xì)
|
| C16-Ceramide |
N-棕櫚酰神經(jīng)鞘氨醇 |
24696-26-2 |
詳細(xì)
|
| Bractoppin |
Bractoppin |
2290527-07-8 |
詳細(xì)
|
| Maralixibat chloride |
HP-625) |
228113-66-4 |
詳細(xì)
|
| JAK2/FLT3-IN-1 |
JAK2/FLT3-IN-1 |
2387765-27-5 |
詳細(xì)
|
| SARS-CoV-2 Mpro-IN-9 |
Hispidulin 4'-O-β-D-glucopyranoside |
244285-12-9 |
詳細(xì)
|
| 15-LOX-1 inhibitor 1 |
9C(I472) |
2349374-37-2 |
詳細(xì)
|
| Lufotrelvir |
化合物PF-07304814 |
2468015-78-1 |
詳細(xì)
|
| GSK778 |
GSK778 |
2451862-42-1 |
詳細(xì)
|
| G6PDi-1 |
4-((5-氧代-6,7,8,9-四氫-5H-環(huán)庚并[D]嘧啶-2-基)氨基)噻吩-2-甲腈 |
2457232-14-1 |
詳細(xì)
|
| XL177A |
化合物XL177A |
2417089-74-6 |
詳細(xì)
|
| BRM/BRG1 ATP Inhibitor-2 |
化合物 BRM/BRG1 ATP INHIBITOR-2 |
2368900-77-8 |
詳細(xì)
|
| Bruceine B |
鴉膽子素B |
25514-29-8 |
詳細(xì)
|
| Terameprocol |
EM-1421 |
24150-24-1 |
詳細(xì)
|
| 2-Phenylethyl isothiocyanate |
2-苯基乙基異硫代氰酸酯 |
2257-09-2 |
詳細(xì)
|
| WDR5-IN-1 |
WDR5-IN-1 |
2408842-51-1 |
詳細(xì)
|
| HPK1-IN-7 |
1(3H)-Isobenzofuranone, 5-[[4-[[(1S)-2-hydroxy-1-phenylethyl]amino]-5-(1,3,4-oxadiazol-2-yl)-2-pyrimidinyl]amino]-3,3-dimethyl- |
2320462-65-3 |
詳細(xì)
|
| ASK1-IN-2 |
1H-Indole-2-carboxamide, 6-fluoro-N-[6-[4-(1-methylethyl)-4H-1,2,4-triazol-3-yl]-2-pyridinyl]- |
2541792-70-3 |
詳細(xì)
|
| dCBP-1 |
化合物DCBP-1 |
2484739-25-3 |
詳細(xì)
|
| IL-17A inhibitor 1 |
化合物IL-17A INHIBITOR 1 |
2452464-73-0 |
詳細(xì)
|
| CA77.1 |
化合物CA77.1 |
2412270-22-3 |
詳細(xì)
|
| Polyinosinic-polycytidylic acid |
聚肌苷-聚胞苷酸復(fù)合物 |
24939-03-5 |
詳細(xì)
|
| Apostatin-1 |
Benzeneacetamide, N-cycloheptyl-α-[(4,5-dihydro-1-methyl-1H-imidazol-2-yl)thio]- |
2559703-06-7 |
詳細(xì)
|
| Adaphostin |
化合物ADAPHOSTIN |
241127-58-2 |
詳細(xì)
|
| VULM 1457 |
VULM 1457 |
228544-65-8 |
詳細(xì)
|
| Wiskostatin |
WISKOSTATIN |
253449-04-6 |
詳細(xì)
|
| Evixapodlin |
(5S,5'S)-5,5'-((((5,5'-(2,2'-dichloro-[1,1'-biphenyl]-3,3'-diyl)bis(3-methoxypyrazine-5,2-diyl))bis(methylene))bis(azanediyl))bis(methylene))bis(pyrrolidin-2-one) |
2374856-75-2 |
詳細(xì)
|
| JKE-1674 |
JKE-1674 |
2421119-60-8 |
詳細(xì)
|
| Pratensein |
紅車軸草素 |
2284-31-3 |
詳細(xì)
|
| ATX inhibitor 5 |
ATX inhibitor 5 |
2402772-45-4 |
詳細(xì)
|
| CU-115 |
化合物CU-115 |
2471982-20-2 |
詳細(xì)
|
| PF-07220060 |
CDK4/6-IN-6 |
2380321-51-5 |
詳細(xì)
|
| Tuspetinib |
化合物HM43239 |
2294874-49-8 |
詳細(xì)
|
| Elenestinib |
化合物BLU-263 |
2505078-08-8 |
詳細(xì)
|
| EB-42486 |
化合物EB-42486 |
2390475-81-5 |
詳細(xì)
|
| GA-017 |
化合物GA-017 |
2351906-74-4 |
詳細(xì)
|
| YS-370 |
化合物YS-370 |
2470908-79-1 |
詳細(xì)
|
| Geranylgeraniol |
香葉基香葉醇 |
24034-73-9 |
詳細(xì)
|
| SU056 |
化合物SU056 |
2376580-08-2 |
詳細(xì)
|
| ZX-29 |
ZX-29 |
2254805-62-2 |
詳細(xì)
|
| SCR130 |
1,7,9-Triazaspiro[4.5]dec-1-ene-6,10-dione, 2,4-bis(4-chlorophenyl)-8-thioxo- |
2377858-38-1 |
詳細(xì)
|
| GMB-475 |
GMB-475 |
2490599-18-1 |
詳細(xì)
|
| (S)-Sunvozertinib |
2-Propenamide, N-[5-[[4-[[5-chloro-4-fluoro-2-(1-hydroxy-1-methylethyl)phenyl]amino]-2-pyrimidinyl]amino]-2-[(3S)-3-(dimethylamino)-1-pyrrolidinyl]-4-methoxyphenyl]- |
2370013-49-1 |
詳細(xì)
|
| TP0586532 |
TP0586532 |
2427584-96-9 |
詳細(xì)
|
| Palmitic acid- |
化合物NCT-58 |
2411429-33-7 |
詳細(xì)
|
| Migoprotafib |
抑制劑 |
2377352-49-1 |
詳細(xì)
|
| Cyclothiazide |
莰烯氯噻嗪 |
2259-96-3 |
詳細(xì)
|
| Nampt-IN-5 |
化合物NAMPT-IN-5 |
2380013-17-0 |
詳細(xì)
|
| Reverse transcriptase-IN-1 |
Reverse transcriptase-IN-1 |
2380001-43-2 |
詳細(xì)
|
| JR14a |
JR14a |
2411440-41-8 |
詳細(xì)
|
| RBN-3143 |
PARP14抑制劑 |
2360853-16-1 |
詳細(xì)
|
| Sovilnesib |
化合物 SOVILNESIB |
2410796-79-9 |
詳細(xì)
|
| Menin-MLL inhibitor 20 |
Carbamic acid, N-[(3R)-1-[[2-[[[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]amino]carbonyl]-4-pyridinyl]methyl]-3-piperidinyl]-, 1,1-dimethylethyl ester |
2448173-47-3 |
詳細(xì)
|
| D-(+)-Cellobiose- |
21-DEOXYCORTISOL |
2479914-04-8 |
詳細(xì)
|
| Lirafugratinib |
化合物FGFR2-IN-3 |
2549174-42-5 |
詳細(xì)
|
| Djalonensone |
交鏈孢霉甲基醚 |
23452-05-3 |
詳細(xì)
|
| Sincalide |
辛卡利特 |
25126-32-3 |
詳細(xì)
|
| Anhydroerythromycin A |
脫水紅霉素 |
23893-13-2 |
詳細(xì)
|
| MAGL-IN-1 |
MAGL-IN-1 |
2324160-91-8 |
詳細(xì)
|
| Enbezotinib |
TPX-0046 |
2359649-81-1 |
詳細(xì)
|
| FLT3-IN-4 |
FLT3-IN-4 |
2304799-09-3 |
詳細(xì)
|
| AES-135 |
AES-135 |
2361659-61-0 |
詳細(xì)
|
| MS31 |
MS31 |
2366264-12-0 |
詳細(xì)
|
| PARP/PI3K-IN-1 |
CAY10749 |
2337386-47-5 |
詳細(xì)
|
| PD-1/PD-L1-IN-NP19 |
化合物PD-1/PD-L1-IN-NP19 |
2377916-66-8 |
詳細(xì)
|
| BSH-IN-1 |
BSH-IN-1 |
2553217-91-5 |
詳細(xì)
|
| Monaschromone |
苦楝萜酮內(nèi)酯 |
22611-36-5 |
詳細(xì)
|
| ASK1-IN-1 |
N-(6-(4-異丙基-4H-1,2,4-三唑-3-基)吡啶-2-基)-3-甲氧基-1-(吡嗪-2-基)-1H-吡唑-4-甲酰胺 |
2411382-24-4 |
詳細(xì)
|
| HS271 |
化合物HS271 |
2410393-15-4 |
詳細(xì)
|
| PLN-1474 |
PLN1474 |
2408065-32-5 |
詳細(xì)
|
| SY-5609 |
7-(二甲基膦基)-3-[2-[[(3S)-6,6-二甲基-3-哌啶基]氨基]-5-(三氟甲基)-4-嘧啶基]-1H-吲哚-6-甲腈 |
2417302-07-7 |
詳細(xì)
|
| GNF2133 |
4-乙基-N-(4-(1-(四氫-2H-吡喃-4-基)-1H-吡咯并[2,3-C]吡啶-3-基)吡啶-2-基)哌嗪-1-甲酰胺 |
2561414-56-8 |
詳細(xì)
|
| Zanzalintinib |
XL092 |
2367004-54-2 |
詳細(xì)
|
| IU1-248 |
Benzonitrile, 4-[3-[2-(4-hydroxy-1-piperidinyl)acetyl]-2,5-dimethyl-1H-pyrrol-1-yl]- |
2307472-03-1 |
詳細(xì)
|
| Pumecitinib |
化合物PUMECITINIB |
2401057-12-1 |
詳細(xì)
|
| IHMT-MST1-58 |
化合物 IHMT-MST1-58 |
2414484-25-4 |
詳細(xì)
|
| VU6015929 |
Benzamide, 4-fluoro-3-[[[5-(1-methyl-1H-pyrazol-3-yl)-3-pyridinyl]methyl]amino]-N-[3-(trifluoromethoxy)phenyl]- |
2442597-56-8 |
詳細(xì)
|
| BAY-3827 |
BAY-3827 |
2377576-35-5 |
詳細(xì)
|
| BAY 2666605 |
化合物BAY 2666605 |
2275774-60-0 |
詳細(xì)
|
| Camonsertib |
(3-內(nèi))-3-[6-[(3R)-3-甲基-4-嗎啉基]-1-(1H-吡唑-3-基)-1H-吡唑并[3,4-B]吡啶-4-基]-8-氧雜雙環(huán)[3.2.1]辛-3-醇 |
2417489-10-0 |
詳細(xì)
|